| 1 |
Diagnostik und Therapie von statinassoziierten Muskelsymptomen |
|
|
| Ursula Kassner,Stefanie Grunwald,Dominik Spira,Nikolaus Buchmann,Thomas Bobbert,Elisabetta Gazzerro,Tim Hollstein,Simone Spuler,Elisabeth Steinhagen-Thiessen |
|
| Der Internist. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis |
|
|
| Qingtao Hou,Caishuang Pang,Yuqin Chen |
|
| American Journal of Cardiovascular Drugs. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Comparison of Oral and Injectable Dosage Forms of Vitamin D3 on Resolving Statin-Induced Myopathy: Single Blinded Randomized Controlled Clinical Trial |
|
|
| Reza Ganji,Ahmad Sa’dinpour,Seyed Massoud Seyedian,Saeed Hesam,Nader Afshari,Adeleh Sahebnasagh |
|
| SN Comprehensive Clinical Medicine. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Advances in the management of statin myopathy |
|
|
| Antonio Gallo,Jeff Perregaux,Eric Bruckert |
|
| Current Opinion in Endocrinology, Diabetes & Obesity. 2021; 28(2): 142 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Vitamin D Supplementation During Statin Rechallenge in Patients With a History of Intolerance |
|
|
| Alison L. P. Compton,Marc J. Pepin,Daniel R. Katzenberger,Debra W. Kemp,Jamie N. Brown |
|
| Annals of Pharmacotherapy. 2021; 55(6): 814 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
The role of vitamin D in statin treated patients complaining of myalagia |
|
|
| Noha Hassanin,Yasser Baghdady,Mohamed Shehata,Ashgan Wagdi |
|
| Cor et Vasa. 2021; 63(1): 58 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism |
|
|
| Tara Warren,Roisin McAllister,Amy Morgan,Taranjit Singh Rai,Victoria McGilligan,Matthew Ennis,Christopher Page,Catriona Kelly,Aaron Peace,Bernard M. Corfe,Mark Mc Auley,Steven Watterson |
|
| Cells. 2021; 10(8): 2007 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications |
|
|
| Patrick J. McCullough,William P. McCullough,Douglas Lehrer,Jeffrey B. Travers,Steven J. Repas |
|
| Nutrients. 2021; 13(5): 1511 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease |
|
|
| James T. Reston,Andrew Buelt,Mark P. Donahue,Brian Neubauer,Elena Vagichev,Kristy McShea |
|
| Annals of Internal Medicine. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study |
|
|
| Harsheen Kaur,Jagjit Singh,Jeet Ram Kashyap,Ravi Rohilla,Harmanjit Singh,Shivani Jaswal,Rajiv Kumar |
|
| European Endocrinology. 2020; 16(2): 137 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance |
|
|
| Stephen J Nicholls,A Michael Lincoff,Harold E Bays,Leslie Cho,Diederick E Grobbee,John JP Kastelein,Peter Libby,Patrick M Moriarty,Jorge Plutzky,Kausik K Ray,Paul D. Thompson,William Sasiela,Denise Mason,Jaclyn McCluskey,Deborah Davey,Kathy Wolski,Steven E Nissen |
|
| American Heart Journal. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
The Vitamin D Assessment (ViDA) study – Design and main findings |
|
|
| Robert Scragg |
|
| The Journal of Steroid Biochemistry and Molecular Biology. 2020; 198: 105562 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Effects of Vitamin D on drugs: Response and disposal |
|
|
| Jinfu Peng,Yanan Liu,Jinlian Xie,Guoping Yang,Zhijun Huang |
|
| Nutrition. 2020; : 110734 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
An overview of statin-induced myopathy and perspectives for the future |
|
|
| Dragana Nikolic,Maciej Banach,Roberta Chianetta,Luca Marco Luzzu,Anca Pantea Stoian,Camelia Cristina Diaconu,Roberto Citarrella,Giuseppe Montalto,Manfredi Rizzo |
|
| Expert Opinion on Drug Safety. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations |
|
|
| Allyson M. Schweitzer,Molly A. Gingrich,Thomas J. Hawke,Irena A. Rebalka |
|
| European Journal of Applied Physiology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis |
|
|
| Katherine Wong,Alexander Podboy,Jonathan Lavezo,Aparna Goel |
|
| Digestive Diseases and Sciences. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Statin-associated muscle symptoms: Does the benefit outweigh the risk factor? |
|
|
| Shannon M. Laboy,Michael T. PULLEY |
|
| Muscle & Nerve. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Overview of results from the Vitamin D Assessment (ViDA) study |
|
|
| R. K. R. Scragg |
|
| Journal of Endocrinological Investigation. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance |
|
|
| Jordon C. Irwin,Andrew S. Fenning,Rebecca K. Vella |
|
| Translational Research. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain |
|
|
| Manuela Pennisi,Giuseppe Di Bartolo,Giulia Malaguarnera,Rita Bella,Giuseppe Lanza,Michele Malaguarnera |
|
| Disease Markers. 2019; 2019: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Statin Toxicity |
|
|
| Natalie C. Ward,Gerald F. Watts,Robert H. Eckel |
|
| Circulation Research. 2019; 124(2): 328 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Magnesium Supplementation in Vitamin D Deficiency |
|
|
| Pramod Reddy,Linda R. Edwards |
|
| American Journal of Therapeutics. 2019; 26(1): e124 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Does vitamin D supplementation prevent statin-induced myopathy? |
|
|
| Esther Papp,Edward E. Rylander |
|
| Evidence-Based Practice. 2019; 22(2): 21 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Does vitamin D supplementation reduce the risk of statin-associated myalgia? |
|
|
| Susie Wenstrup,Adriana Santana,Amanda Jamal |
|
| Evidence-Based Practice. 2019; 22(9): 16 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Statin-related myopathies |
|
|
| David Hilton-Jones |
|
| Practical Neurology. 2018; 18(2): 97 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Dyslipidaemia in the elderly: to treat or not to treat? |
|
|
| Niki Katsiki,Genovefa Kolovou,Pablo Perez-Martinez,Dimitri P. Mikhailidis |
|
| Expert Review of Clinical Pharmacology. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Important drug-micronutrient interactions: A selection for clinical practice |
|
|
| Uwe Gröber,Joachim Schmidt,Klaus Kisters |
|
| Critical Reviews in Food Science and Nutrition. 2018; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Statin-Associated Muscle Disease: Advances in Diagnosis and Management |
|
|
| Beth A. Taylor,Paul D. Thompson |
|
| Neurotherapeutics. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen |
|
|
| Gerald Klose |
|
| MMW - Fortschritte der Medizin. 2018; 160(1): 40 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study |
|
|
| Zhenqiang Wu,Carlos A. Camargo,Kay-Tee Khaw,Debbie Waayer,Carlene M.M. Lawes,Les Toop,Robert Scragg |
|
| Atherosclerosis. 2018; 273: 59 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases |
|
|
| Parth Shah |
|
| Current Cardiology Reports. 2018; 20(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Practical aspects in the management of statin-associated muscle symptoms (SAMS) |
|
|
| Ulrich Laufs,Krysztof J. Filipiak,Ioanna Gouni-Berthold,Alberico L. Catapano,Giuseppe Mandraffino,Pascale Benlian |
|
| Atherosclerosis Supplements. 2017; 26: 45 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort |
|
|
| Nikhil Sharma,Rachel Cooper,Diana Kuh |
|
| Scientific Reports. 2017; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels |
|
|
| Rupinder Singh Buttar,Jasveen Batra,Jacqueline Kreimerman,Melissa Aleta,Michal L. Melamed |
|
| Journal of General Internal Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Statins Everyday Versus Alternate days: Is There a Difference in Myalgia rates? |
|
|
| Ramsha Riaz,Aleena Zehra Merchant,Muhammad Salman Ul Haq,Syed Ali Raza Nasir,Yusra Rizvi,Jehanzeb Ahmed Khan,Sara Mohiuddin Zakaria,Hassaan Jawed,Khizar Hamid,Noor-ul-ain Zehra,Madiha Ahmed,Hussain Asif Ali,Kaneez Fatima |
|
| Indian Heart Journal. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Myotoxicity of statins: Mechanism of action |
|
|
| Patrick du Souich,Ghislaine Roederer,Robert Dufour |
|
| Pharmacology & Therapeutics. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Statins, Muscle Disease and Mitochondria |
|
|
| Radha Ramachandran,Anthony Wierzbicki |
|
| Journal of Clinical Medicine. 2017; 6(8): 75 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Neurological Complications of Nutritional Deficiencies |
|
|
| Aparna Polavarapu,Daphne Hasbani |
|
| Seminars in Pediatric Neurology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Vitamin D Deficiency, Supplementation, and Cardiovascular Health |
|
|
| Naveen Trehan,Luis Afonso,Diane L. Levine,Phillip D. Levy |
|
| Critical Pathways in Cardiology. 2017; 16(3): 109 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Trial designs for statin muscle intolerance |
|
|
| Robert S. Rosenson |
|
| Current Opinion in Lipidology. 2017; 28(6): 488 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients |
|
|
| Leonardo Calza,Eleonora Magistrelli,Vincenzo Colangeli,Marco Borderi,Ilaria Contadini,Isabella Bon,Maria Carla Re,Pierluigi Viale |
|
| AIDS. 2017; 31(5): 681 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults |
|
|
| Heike A. Bischoff-Ferrari,Karina Fischer,Endel J. Orav,Bess Dawson-Hughes,Ursina Meyer,Patricia O. Chocano-Bedoya,Otto W. Meyer,Rahel Ernst,Simeon Schietzel,Franz Eberli,Hannes B. Staehelin,Gregor Freystätter,Susanne Roas,Robert Theiler,Andreas Egli,Nicholas M. Wilson |
|
| Journal of the American Geriatrics Society. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care |
|
|
| Susan E. Merel,Douglas S. Paauw |
|
| Journal of the American Geriatrics Society. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study |
|
|
| Parth Shah,Charles J. Glueck,Naila Goldenberg,Sarah Min,Chris Mahida,Ilana Schlam,Matan Rothschild,Ali Huda,Ping Wang |
|
| Lipids in Health and Disease. 2017; 16(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study |
|
|
| Joshua Choi,Amir M Khan,Michael Jarmin,Naila Goldenberg,Charles J Glueck,Ping Wang |
|
| Lipids in Health and Disease. 2017; 16(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight |
|
|
| Cynthia Geyer |
|
| American Journal of Lifestyle Medicine. 2016; 10(5): 348 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol =70 mg/dl despite maximal tolerated cholesterol lowering therapy |
|
|
| Charles J. Glueck,Parth Shah,Naila Goldenberg,Marloe Prince,Kevin Lee,Vybhav Jetty,Ashwin Kumar,Michael Goldenberg,Ping Wang |
|
| Lipids in Health and Disease. 2016; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center |
|
|
| Parth Shah,Charles J. Glueck,Vybhav Jetty,Naila Goldenberg,Matan Rothschild,Rashid Riaz,Gregory Duhon,Ping Wang |
|
| Lipids in Health and Disease. 2016; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Statin myopathy |
|
|
| Negar Maghsoodi,Anthony S. Wierzbicki |
|
| Current Opinion in Cardiology. 2016; 31(4): 417 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática |
|
|
| Claudia Alejandra Pereda,Maria Betina Nishishinya |
|
| Reumatología Clínica. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review |
|
|
| Claudia Alejandra Pereda,Maria Betina Nishishinya |
|
| Reumatología Clínica (English Edition). 2016; 12(6): 331 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)1 |
|
|
| Harold Bays,Shanu N. Kothari,Dan E. Azagury,John M. Morton,Ninh Nguyen,Peter H. Jones,Terry A. Jacobson,David Cohen,Carl Orringer,Eric C. Westman,Deborah B. Horn,Wendy Scinta,Craig Primack |
|
| Surgery for Obesity and Related Diseases. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain |
|
|
| Beth A. Taylor,Lindsay Lorson,Michael White,Paul D. Thompson |
|
| Atherosclerosis. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol |
|
|
| Laura A. Della Badia,Nabil A. Elshourbagy,Shaker A. Mousa |
|
| Pharmacology & Therapeutics. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 55 |
Statin intolerance – a question of definition |
|
|
| Engi Abdel-Hady Algharably,Iris Filler,Stephanie Rosenfeld,Katja Grabowski,Reinhold Kreutz |
|
| Expert Opinion on Drug Safety. 2016; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 56 |
The Risks and Benefits of Sun Exposure 2016 |
|
|
| David G. Hoel,Marianne Berwick,Frank R. de Gruijl,Michael F. Holick |
|
| Dermato-Endocrinology. 2016; : 00 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence |
|
|
| Scott A. Coon,Emily J. Ashjian,Megan C. Herink |
|
| Current Cardiovascular Risk Reports. 2016; 10(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? |
|
|
| Amirhossein Sahebkar,Nikou Saboni,Matteo Pirro,Maciej Banach |
|
| Journal of Cachexia, Sarcopenia and Muscle. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons |
|
|
| Seema Patel |
|
| World Journal of Microbiology and Biotechnology. 2016; 32(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 60 |
Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) |
|
|
| G. B. John Mancini,Steven Baker,Jean Bergeron,David Fitchett,Jiri Frohlich,Jacques Genest,Milan Gupta,Robert A. Hegele,Dominic Ng,Glen J. Pearson,Janet Pope,A. Yashar Tashakkor |
|
| Canadian Journal of Cardiology. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 61 |
Statin-related myotoxicity |
|
|
| Vera Fernandes,Maria Joana Santos,Antonio Pérez |
|
| Endocrinología y Nutrición (English Edition). 2016; 63(5): 239 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 62 |
Statin-related myotoxicity |
|
|
| Vera Fernandes,Maria Joana Santos,Antonio Pérez |
|
| Endocrinología y Nutrición. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 63 |
Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon |
|
|
| Chandan Prasad,Victorine Imrhan,Shanil Juma,Mindy Maziarz,Anand Prasad,Casey Tiernan,Parakat Vijayagopal |
|
| Metabolites. 2015; 5(4): 733 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
